🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well everolimus and hormone therapy work in...
Status
Terminated
Location
Emory University Hospital Midtown
Start Date
2014-11-25
Trial ID
NCT02269670
Treatments Being Tested
Surgery for hilar cholangiocarcinoma (phCCA) remains a significant challeng...
Status
Recruiting
Location
Oslo University Hospital
Start Date
2025-01-01
Trial ID
NCT06850753
Treatments Being Tested
BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Status
Completed
Location
Unit of Endocrinology and Metabolic Diseases
Start Date
2019-11-27
Trial ID
NCT04196231
Treatments Being Tested
This randomized controlled trial aims to evaluate the short-term effects of...
Status
Completed
Location
UOP
Start Date
2024-08-01
Trial ID
NCT07133373
Treatments Being Tested
Children with West syndrome are prone to refractory seizures with poor neur...
Status
Unknown
Location
All India Institute of Medical Sciences
Start Date
2022-04-18
Trial ID
NCT05279118
Treatments Being Tested
This phase II trial is studying how well 17-AAG works in treating patients ...
Status
Completed
Location
Mayo Clinic
Start Date
2005-01
Trial ID
NCT00118092
Treatments Being Tested
The goals of this clinical research study are to learn the tolerable and ef...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2009-11
Trial ID
NCT00903006
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of van...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT01004419
Treatments Being Tested
This study aims to compare two commonly used hormone treatments for women u...
Status
Completed
Location
Centrum Clinic IVF Center
Start Date
2026-02-05
Trial ID
NCT07348757
This is a Phase 1/Phase 2 study assessing liothyronine (L-T3) immunotherapy...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2026-08-21
Trial ID
NCT07346157
Treatments Being Tested